Hydronephrosis surgery
|
Hydronephrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hydronephrosis surgery On the Web |
|
American Roentgen Ray Society Images of Hydronephrosis surgery |
|
Risk calculators and risk factors for Hydronephrosis surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
- Surgery is the mainstay of treatment for Hydronephrosis. The type of surgery depends on the underlying cause and also depending on whether the obstruction is acute or chronic.
Surgery
Treatment of hydronephrosis focuses upon the removal of the obstruction and drainage of the urine that has accumulated behind the obstruction. Therefore, the specific treatment depends upon where the obstruction lies, and whether it is acute or chronic.
Acute obstruction of the upper urinary tract is usually treated by the insertion of a nephrostomy tube. Chronic upper urinary tract obstruction is treated by the insertion of a ureteric stent or a pyeloplasty.[1][2][3]
Lower urinary tract obstruction (such as that caused by bladder outflow obstruction secondary to prostatic hypertrophy) is usually treated by insertion of a urinary catheter or a suprapubic catheter.
Surgery is not required in all cases.[4]
Indications
- Surgical intervention is not recommended for the management of [disease name].
OR
- Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]
Surgery
- The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
OR
- Surgery is the mainstay of treatment for [disease or malignancy].
Contraindications
References
- ↑ Liu KL, Lee BC, Ye JD, Chang YH, Chang CC, Huang KH, Lee YJ, Chang YC (July 2018). "Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients". Eur Radiol. doi:10.1007/s00330-018-5560-6. PMID 29974220.
- ↑ Şimşir A, Kızılay F, Semerci B (April 2018). "Comparison of percutaneous nephrostomy and double J stent in
symptomatic pregnancy hydronephrosis treatment". Turk J Med Sci. 48 (2): 405–411. doi:10.3906/sag-1711-5. PMID 29714462. line feed character in
|title=at position 61 (help) - ↑ Li B, Liu DB, Gong EM (June 2018). "Robot-assisted laparoscopic transplant-to-native ureteroureterostomy of an intraperitoneal renal allograft". J Pediatr Urol. doi:10.1016/j.jpurol.2018.06.008. PMID 30017605.
- ↑ Onen A (2007). "Treatment and outcome of prenatally detected newborn hydronephrosis". J Pediatr Urol. 3 (6): 469–76. doi:10.1016/j.jpurol.2007.05.002. PMID 18947797. Unknown parameter
|month=ignored (help)